{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:13:52Z","timestamp":1779232432771,"version":"3.51.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1245\/s10434-022-11985-4","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T19:14:58Z","timestamp":1654629298000},"page":"5355-5356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Can We Predict Surgical Futility\/Cure in Gallbladder Cancer?"],"prefix":"10.1245","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7753-097X","authenticated-orcid":false,"given":"Travis","family":"Grotz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"11985_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5005\/jp-journals-10018-1348","volume":"11","author":"S Naveed","year":"2021","unstructured":"Naveed S, Qari H, Thau CM, et al. Neoadjuvant chemotherapy for advanced gallbladder cancer: do we have enough evidence? A systematic review. Euroasian J Hepatogastroenterol. 2021;11:87\u201394.","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"11985_CR2","doi-asserted-by":"publisher","unstructured":"Shimizu Y, Ashida R, Sugiura T, et al. Early recurrence in resected gallbladder carcinoma: clinical impact and its preoperative predictive score. Ann Surg Oncol. 2022. https:\/\/doi.org\/10.1245\/s10434-022-11937-y.","DOI":"10.1245\/s10434-022-11937-y"},{"key":"11985_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3390\/cancers13051089","volume":"13","author":"M Kim","year":"2021","unstructured":"Kim M, Kim H, Han Y, et al. Prognostic value of carcinoembryonic antigen (CEA) and carbohydrate antigen 19\u20139 (CA 19\u20139) in gallbladder cancer; 65 IU\/mL of CA 19\u20139 is the new cut-off value for prognosis. Cancers (Basel). 2021;13:1089.","journal-title":"Cancers (Basel)"},{"key":"11985_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1159\/000506628","volume":"37","author":"Y Yamamoto","year":"2020","unstructured":"Yamamoto Y, Sugiura T, Okamura Y, et al. Surgical indication for advanced gallbladder cancer considering the optimal preoperative carbohydrate antigen 19\u20139 cutoff value. Dig Surg. 2020;37:390\u2013400.","journal-title":"Dig Surg"},{"key":"11985_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/17246008211068866","volume":"37","author":"X Zhou","year":"2022","unstructured":"Zhou X. Meta-analysis of the diagnostic performance of serum carbohydrate antigen 19\u20139 for the detection of gallbladder cancer. Int J Biol Markers. 2022;37:81\u20139.","journal-title":"Int J Biol Markers"},{"key":"11985_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1477-2574.2009.00149.x","volume":"12","author":"I Hatzaras","year":"2010","unstructured":"Hatzaras I, Schmidt C, Muscarella P, et al. Elevated CA 19\u20139 portends poor prognosis in patients undergoing resection of biliary malignancies. HPB (Oxford). 2010;12:134\u20138.","journal-title":"HPB (Oxford)"},{"key":"11985_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1001\/jamasurg.2020.2497","volume":"155","author":"J Xiao","year":"2020","unstructured":"Xiao J, Caan BJ, Cespedes Feliciano EM, et al. Association of low muscle mass and low muscle radiodensity with morbidity and mortality for colon cancer surgery. JAMA Surg. 2020;155:942\u20139.","journal-title":"JAMA Surg"},{"key":"11985_CR8","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s11605-018-3802-1","volume":"22","author":"J Chakedis","year":"2018","unstructured":"Chakedis J, Spolverato G, Beal EW, et al. Pre-operative sarcopenia identifies patients at risk for poor survival after resection of biliary tract cancers. J Gastrointest Surg. 2018;22:1697\u2013708.","journal-title":"J Gastrointest Surg"},{"key":"11985_CR9","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1245\/s10434-020-08858-z","volume":"28","author":"H Kuipers","year":"2021","unstructured":"Kuipers H, de Savornin Lohman EAJ, van Dooren M, et al. Extended resections for advanced gallbladder cancer: results from a nationwide cohort study. Ann Surg Oncol. 2021;28:835\u201343.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-11985-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T17:14:09Z","timestamp":1659806049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-11985-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["11985"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-11985-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author has nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}